Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma

BACKGROUND: Tumor immune microenvironment (TIME) and cancer antigen expression, key factors for the development of immunotherapies, are usually based on the data from primary tumors due to availability of tissue for analysis; data from metastatic sites and their concordance with primary tumor are la...

Descripción completa

Detalles Bibliográficos
Autores principales: Restle, David, Dux, Joseph, Li, Xiaoyu, Byun, Alexander J, Choe, Jennie K, Li, Yan, Vaghjiani, Raj G, Thomas, Carlos, Misawa, Kyohei, Tan, Kay See, Jones, David R, Chintala, Navin K, Adusumilli, Prasad S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314697/
https://www.ncbi.nlm.nih.gov/pubmed/37349126
http://dx.doi.org/10.1136/jitc-2022-006609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314697/
https://www.ncbi.nlm.nih.gov/pubmed/37349126
http://dx.doi.org/10.1136/jitc-2022-006609

Ejemplares similares